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After 16 years negotiation, China had become the 143rd member of WTO on Dec.11, 
2001.According to the promise of participating WTO, China will enlarge the 
opening to the world on the territories of Industry, agriculture, service, etc, faster 
impelling trading liberalization and convenient of investment. During the course of 
performing, China will push domestic economy into a fresh stage, via deepen 
reforming of trading system, completing trading legal system, reducing trading 
border and government intervene. While, with the completely opening of trading 
rights, more and more chemical and pharmaceutical companies contacted directly 
with end customers and market, competed with trading companies directly. And 
more and more customers, especially overseas customers are willing to contact with 
original manufacturers directly. All the changes have brought great impact to trading 
companies, which get profits via trading purely.  
This paper based on China trading companies’ developing, combining chemical and 
pharmaceutical companies’ characters, analyzed local chemical and pharmaceutical 
trading companies’ characters and threats, through illustration and analysis from 
background change and business model developing, trying to discuss the key success 
factors and experience, based on value chain and market situation, to give some 
feasible suggestions for small and middle trading companies in chemical and 
pharmaceutical industry. 
This paper referring to FHCC’s development and history, give SWOT analysis and 
indicate FHCC’s advantage and disadvantage. Combining with Michael Porter's 
competition theory, illustrate the selection of FHCC in related segment and niche 
market. And referring to present economic trend, give strategic plan to FHCC. 
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2010 年 1 至 11 月，我国医药工业实现现价工业生产总值 11239.53 亿元，
同比增长 26.35%，市场细分见图 1-1。随着全球金融危机回暖，医药工业生产
趋于稳步增长态势，预计 2012 年医药工业总产值将超过 1.5 万亿元。从宏观层
面看，我国经济增长态势良好，但受医疗体制改革和价格调整的影响，产销率
略有下降。在国际医药市场全面恢复以及国内医药市场大幅扩容的情况下，2010
年国内医药行业进出口均保持了高速增长。在进出口方面，截至到 2010 年 11
月，我国医药工业累计出口额达到 357.98 亿美元，同比增长 26.23%；累计进
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西方关于企业营销战略管理的研究出现在 20 世纪 50 年代末和 60 年代初，
如图 2-1 所示，市场营销理论的核心内容就是 4P，“4P”是以产品
（Production）、价格（Price）、地点（Place）、促销手段（Promotion）为代
表的、以生产为中心的营销四要素组合的总称。在整个 20 世纪 80 代与 90 年代，
企业的营销更多的运用“4P”策略，后来在“4P”营销观的基础上，加上“权
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